As leader of Stanford’s Cancer Computational and Systems Biology group, Christina Curtis, one of In Vivo’s 2021 Rising Leaders, is working to shed new light on the mysteries of metastatic cancer. Curtis’s use of computational models to analyze genetic mutations in breast cancer earned her an NIH Director’s Pioneer Award.
Back To Rising Leaders Gallery
As with many aspects of human biology, the closer one looks, the more complicated and chaotic things become. Not only...
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
From solving delivery challenges for Moderna's COVID-19 vaccine to pioneering the next generation of programmable medicines, the 2025 Rising Leader provides mid-career reflections.
The mathematician-turned-CEO is building an atlas of clinical immune biology to revolutionize precision medicine.
A 25-year-old's “naive optimism” becomes the driving force behind one of biopharma's most ambitious AI ventures.
The Stanford professor-turned-CEO's 15-year journey demonstrates how scientific vision and focused leadership can revolutionize pharmaceutical supply chains.
The Japanese pharma specialist has embarked on an ambitious journey to become a global specialty pharmaceutical company, driven by its first non-Japanese president at the helm.
Aviv Regev is betting AI-driven drug discovery can transform Genentech's pipeline, with early wins validating her computational biology approach to pharmaceutical R&D.
The culmination of the MedTech Innovator APAC awards program 2025 comes later this month when the top prizes are handed out at the grand final in Singapore. But all cohort companies benefit from the competition’s mentoring process, says awards organizer Fredrik Nyberg.
